Holen Sie sich die Stockscreener-App
0.3634
2.08%
-0.0066
Handel nachbörslich:
.36
-0.0034
-0.94%
Schlusskurs vom Vortag:
$0.37
Offen:
$0.3592
24-Stunden-Volumen:
163.37K
Relative Volume:
0.32
Marktkapitalisierung:
$7.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-0.169
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
+12.94%
1M Leistung:
+2.46%
6M Leistung:
-90.78%
1J Leistung:
-89.31%
1-Tages-Spanne:
$0.35
$0.367
1-Wochen-Bereich:
$0.3264
$0.394
52-Wochen-Spanne:
$0.3011
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Vergleichen Sie NVNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.3634 | 7.48M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - fdlreporter.com
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Times Herald-Record
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Fall River Herald News
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Is enVVeno Medical Corporation (5HJ) stock positioned for secular growth2025 Sector Review & Technical Pattern Based Buy Signals - Улправда
NVNBW SEC FilingsEnvveno Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Can enVVeno Medical Corporation stock deliver sustainable ROE2025 Market Outlook & Verified High Yield Trade Plans - ulpravda.ru
Will enVVeno Medical Corporation stock pay special dividends2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
How enVVeno Medical Corporation stock reacts to inflationary pressuresWeekly Risk Summary & Advanced Technical Signal Analysis - Улправда
How enVVeno Medical Corporation stock benefits from global expansion2025 Bull vs Bear & Daily Stock Momentum Reports - Улправда
Will enVVeno Medical Corporation stock sustain high P E ratios2025 Trading Volume Trends & Technical Entry and Exit Tips - Улправда
Can enVVeno Medical Corporation stock hit record highs againAnalyst Downgrade & Real-Time Market Trend Scan - Улправда
Why enVVeno Medical Corporation stock is rated strong buyJuly 2025 PostEarnings & Stepwise Trade Signal Guides - Улправда
Will enVVeno Medical Corporation stock outperform Nasdaq index2025 Trading Volume Trends & High Accuracy Investment Entry Signals - Улправда
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
[Form 4] enVVeno Medical Corp Insider Trading Activity - Stock Titan
enVVeno Medical (NVNO) CTO surrenders 50,000 performance RSUs - Stock Titan
Is enVVeno Medical Corporation stock ready for breakoutPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Why enVVeno Medical Corporation stock remains on buy listsRecession Risk & Real-Time Volume Analysis - Улправда
Will enVVeno Medical Corporation stock benefit from infrastructure spending2025 AllTime Highs & Accurate Buy Signal Notifications - Улправда
enVVeno Medical (NVNO) details director stock option award of 135,883 - Stock Titan
enVVeno Medical Corp (NVNO) director receives 135,883 stock options - Stock Titan
enVVeno Medical Corp (NVNO) director awarded 135,883 options on December 11, 2025 - Stock Titan
enVVeno Medical Corp (NVNO) director gets 135,883 stock options vesting in 2026 - Stock Titan
EnVVeno Medical shareholders approve reverse stock split, reject equity plan By Investing.com - Investing.com India
enVVeno Medical (NVNO) director sells 4,900 shares under 10b5-1 plan - Stock Titan
enVVeno Medical Holds Annual Stockholders Meeting - TipRanks
EnVVeno Medical shareholders approve reverse stock split, reject equity plan - Investing.com
[8-K] enVVeno Medical Corp Reports Material Event | NVNO SEC FilingForm 8-K - Stock Titan
What drives enVVeno Medical Corporation stock pricePrice Action Analysis & Low Cost Wealth Plans - earlytimes.in
A History of Outperforming Analyst Forecasts and Beating the Odds: enVVeno Medical Corporation (NVNO) - setenews.com
enVVeno Medical Shares Continue to Face Downward Pressure - AD HOC NEWS
Is enVVeno Medical Corporation (5HJ) stock a good hedge against inflation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
How enVVeno Medical Corporation (5HJ) stock reacts to stronger dollarJuly 2025 Action & Target Return Focused Picks - Newser
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulus2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Why enVVeno Medical Corporation stock is favored by top institutionsEntry Point & Stock Market Timing Techniques - Newser
Is enVVeno Medical Corporation (5HJ) stock undervalued by metricsMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
How enVVeno Medical Corporation stock compares to industry benchmarks2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock resilient in recession scenariosTrade Entry Report & AI Forecasted Entry/Exit Points - Newser
Can enVVeno Medical Corporation (5HJ) stock deliver double digit returnsWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock worth holding before Fed meetingTrade Exit Summary & Weekly Breakout Stock Alerts - Newser
enVVeno Medical (NASDAQ: NVNO) adds reverse stock split vote to 2025 meeting - Stock Titan
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
The growth track for enVVeno Medical Corporation (NVNO) has changed recently - setenews.com
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):